Dr Fadzilah Adibah pioneering the commercial medical research of herbal and marine based health supplement, bridging the research activities to conform to industrial need and the regulatory requirement following the international standards. She leads the commercial research on herbal supplement for diabetes, arthritis and cancer. She is currently consulting on health products research and development to a bionexus status company, Proliv Life Sciences Sdn Bhd and research based company Naturemedic Laboratories Sdn Bhd for commercialization activities. Herbal supplement for diabetes named Aidecine™ (MAL15080016TC), Glicatrim™ (MAL20152498TCE/USFDA) and Synacinn™ (MAL ) are the three most recently approved herbal supplements developed through university research and is going into commercialization exercise. She is a committee member of Cosmetics Safety Expert Committee (CoSEC) for National Pharmaceutical Control Bureau (NPCB), Ministry of Health, Malaysia since 2010. University based research needs an international platform for commercialization networking. Thus, she recently engages with non-profit organization PUGM (Malaysia Graduate Entrepreneurs Association) based in Kuala Lumpur to initiate networking with fellow graduate entrepreneurs from ASEAN countries and China. Her research leadership is strengthen by a team of 21 PhDs, 30 Masters degrees and more than 100 undergraduates. She published internationally and locally more than 150 papers with ranks (May 2016): 306 citations/H-index 8 (Google scholars), 191 citation/H-index 6 (Scopus). She is actively giving public lectures on functional foods and herbal health talks nationwide